Koskinas Kc 1

1. 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy
2. 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
3. 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
4. 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
5. 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
6. 2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias
7. 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes
8. 2024 ESC Guidelines for the management of peripheral arterial and aortic diseases : Developed by the task force on the management of peripheral arterial and aortic diseases of the European Society of Cardiology (ESC Endorsed by the European Association for Cardio-Thoracic Surgery (EACTS, the European Reference Network on Rare Multisystemic Vascular Diseases (VASCERN, and the European Society of Vascular Medicine (ESVM)
9. 2024 ESC Guidelines for the management of elevated blood pressure and hypertension
10. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC
11. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
12. 2025 ESC/EACTS Guidelines for the management of valvular heart disease: Developed by the task force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)
13. 2025 ESC Guidelines for the management of myocarditis and pericarditis
14. Navigating between Scylla and Charybdis: challenges and strategies for implementing guideline-directed medical therapy in heart failure with reduced ejection fraction
15. 2021 ESC/EACTS Guidelines for the management of valvular heart disease
16. 2021 ESC/EACTS Guidelines for the management of valvular heart disease: Developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)
17. 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)
18. 2024 ESC Guidelines for the management of chronic coronary syndromes
19. 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
1